Abacus dx COSA 2025
Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.
Abacus dx COSA 2025 Conference Showcase
Abacus dx creates value by connecting innovative global suppliers with Australasian customers. We are proud to partner with leading suppliers to meet our customers’ needs.
Contact our team and discover more about our extensive range of specialised solutions.
Asuragen
Asuragen’s molecular assays are designed to provide streamlined workflow and ease of use and is comprised of two product portfolios; Genetics and Oncology. The genetics portfolio includes assays aiding in the detection of the FMR1 and C9orf72 gene, while the Oncology assays use molecular methods ranging from qPCR to NGS to assist our understanding of cancer.
